Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal Article (Journal Article)

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.

Full Text

Duke Authors

Cited Authors

  • Barth, M; Xavier, AC; Armenian, S; Audino, AN; Blazin, L; Bloom, D; Chung, J; Davies, K; Ding, H; Ford, JB; Galardy, PJ; Hanna, R; Hayashi, R; Lee-Miller, C; Machnitz, AJ; Maloney, KW; Marks, L; Martin, PL; McCall, D; Pacheco, M; Reilly, AF; Roshal, M; Song, S; Weinstein, J; Zarnegar-Lumley, S; McMillian, N; Schonfeld, R; Sundar, H

Published Date

  • November 2022

Published In

Volume / Issue

  • 20 / 11

Start / End Page

  • 1267 - 1275

PubMed ID

  • 36351334

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2022.0057


  • eng

Conference Location

  • United States